IGNITE is a high‑science medical education program designed to spark transformative learning across therapeutic areas for healthcare professionals. More than a resource, it is a catalyst that empowers HCPs to expand their knowledge and elevate their clinical practice.
At Celltrion, we believe progress happens when healthcare providers connect, communicate, and collaborate. Through IGNITE, we foster these vital exchanges, driving innovation in disease management and enhancing patient care worldwide.
Tumor necrosis factor (Anti-TNF) inhibitor therapy has shaped inflammatory bowel disease (IBD) care for nearly three decades, and during that time the definition of treatment success has profoundly changed. Watch Dr. Marla Dubinsky's preview video and select the “Sign Up” button to register on igniteHCP.com for access to the full educational video.
US—26-00090-v1.0 07/2026
Sign upA Journey Through the Role Anti-TNFs Play in IBD From Symptom Control to Durable Remission.

This presentation addresses the burdens clinicians and patients experience within the current therapeutic landscape of the anti-TNF therapy class for the management of IBD and utilizes the updated ACG guidelines to review treatment options and maintenance strategies.

Watch a full overview ot the IGNITE Platform and see how it supports your learning journey across inflammatory diseases.
Sign up to gain access to all materials available on the website!
Want to stay at the burning edge of scientific knowledge and disease education? Sign up to receive notifications as soon as new resources, courses, and updates are added to our website.





